2010
DOI: 10.1038/nrneph.2010.19
|View full text |Cite
|
Sign up to set email alerts
|

Emerging erythropoiesis-stimulating agents

Abstract: The stimulation of erythropoiesis is a rapidly evolving area of research, with mechanistic insights often developing rapidly into therapeutic agents. A broad range of erythropoiesis-stimulating agents are currently in clinical use and many more under development are likely to enter the marketplace in the near future. To date, much of the investigative activity in this field has targeted activation of the erythropoietin receptor and factors that modulate hypoxia-related pathways of erythropoietin production wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 61 publications
0
7
0
Order By: Relevance
“…This hydroxylase inhibition increases HIF-1α stability and as such impairs the binding of von Hippel-Lindau protein (pVHL) to HIF-1α, resulting in steady accumulation of HIF complexes within the cell nucleus [11]. Hydroxylase inactivity allows HIF-1α to become transcriptionally active for the up-regulation of a large number of hypoxia-sensitive genes [12]. HIF-1α binds to the core DNA sequence of 5'-[AG]CGTG-3' at the hypoxia response element of target gene promoters.…”
Section: Introductionmentioning
confidence: 99%
“…This hydroxylase inhibition increases HIF-1α stability and as such impairs the binding of von Hippel-Lindau protein (pVHL) to HIF-1α, resulting in steady accumulation of HIF complexes within the cell nucleus [11]. Hydroxylase inactivity allows HIF-1α to become transcriptionally active for the up-regulation of a large number of hypoxia-sensitive genes [12]. HIF-1α binds to the core DNA sequence of 5'-[AG]CGTG-3' at the hypoxia response element of target gene promoters.…”
Section: Introductionmentioning
confidence: 99%
“…BPGM can decrease the oxygen affinity of hemoglobin in red blood cells, thus helping to compensate for tissue oxygen insufficiency [ 26 ]. Meanwhile, XK (X-Linked Kx Blood Group) and HEMGN (Hemogen) are positively associated with erythrocyte and hematopoietic cell generation, proliferation, and differentiation [ 27 , 28 ], which can be stimulated by hypoxia and inflammation [ 29 31 ]. These changes in hypoxia- and inflammation-related genes may indicate hypoxia and inflammation in the transplanted heart and can be used as biomarkers.…”
Section: Discussionmentioning
confidence: 99%
“…However, it has not been proven that intensified Hb >11 g/dL utilizing exogenic EPO translates into a comprehensive benefit for the patients. 5 , 7 New developments promise interesting therapeutic options not only by stimulating erythropoiesis but also by modulating additional mechanisms. In addition to erythropoiesis, EPO has also been reported to have other effects, such as tissue protection and neuroprotection.…”
Section: Discussionmentioning
confidence: 99%